2,3-Diphenyl-2,3-dihydro-4H-1,3-thiaza-4-one heterocycles inhibit growth and block completion of cytokinesis in kinetoplastid parasites.

Cell cycle Crithidia fasciculata Cytokinesis Mitochondria Pyridothiazinone Trypanosoma brucei

Journal

Molecular and biochemical parasitology
ISSN: 1872-9428
Titre abrégé: Mol Biochem Parasitol
Pays: Netherlands
ID NLM: 8006324

Informations de publication

Date de publication:
09 2021
Historique:
received: 12 11 2020
revised: 07 07 2021
accepted: 09 07 2021
pubmed: 25 7 2021
medline: 14 1 2022
entrez: 24 7 2021
Statut: ppublish

Résumé

Kinetoplastid parasites are model eukaryotes with a complex cell cycle that is highly regulated both spatially and temporally. In addition, diseases caused by these parasites continue to have a significant impact on human and animal health worldwide. While there have been advancements in chemotherapy for these diseases, there is a continual need for an arsenal of compounds that have robust anti-parasite activity with minimal impact on the human host. While investigating a series of 2,3-diphenyl-2,3-dihydro-4H-1,3-thiaza-4-one heterocycles with potential activity against these parasites, we found a pyridothiazinone that inhibits growth of the monoxenous parasite Crithidia fasciculata and two life cycle stages of Trypanosoma brucei. This inhibition is more pronounced in T. brucei and is associated with an unusual pre-abscission cell cycle arrest. Exploring the mode of action for these and related compounds in kinetoplastids may provide tools with which to explore cell cycle regulation in these important organisms.

Identifiants

pubmed: 34302898
pii: S0166-6851(21)00043-8
doi: 10.1016/j.molbiopara.2021.111396
pii:
doi:

Substances chimiques

Biphenyl Compounds 0
diphenyl 2L9GJK6MGN

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

111396

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Auteurs

Madeline F Malfara (MF)

Department of Biology, Villanova University, Villanova, PA, 19085, USA.

Lee J Silverberg (LJ)

Pennsylvania State University, Schuylkill Campus, Schuylkill Haven, PA, 17972, USA.

John DiMaio (J)

Pennsylvania State University, Brandywine Campus, Media, PA, 19063, USA.

Anthony F Lagalante (AF)

Department of Chemistry, Villanova University, Villanova, PA, 19085, USA.

Mark A Olsen (MA)

Department of Chemistry, Villanova University, Villanova, PA, 19085, USA.

Ekaterina Madison (E)

Pennsylvania State University, Brandywine Campus, Media, PA, 19063, USA.

Megan L Povelones (ML)

Department of Biology, Villanova University, Villanova, PA, 19085, USA. Electronic address: megan.povelones@villanova.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH